Portfolio Holdings Detail for ISIN IE00B6SPMN59

Stock Name / Fund	iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VI Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300VML6THE3JJOS76
ETF Ticker	SPMV(USD) LSE
ETF Ticker	IBCK(EUR) F
ETF Ticker	MVUS.MI(EUR) CXE
ETF Ticker	SPLVz(CHF) CXE
ETF Ticker	SPMV.LS(USD) CXE
ETF Ticker	MVUS(EUR) ETF Plus
ETF Ticker	SPMV(EUR) ETF Plus
ETF Ticker	SPMV.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-11-11 (Tuesday)	263,394	USD 23,955,684	USD 23,955,684	5,278	USD 1,564,121	USD 90.95	USD 86.75
2025-11-10 (Monday)	258,116	USD 22,391,563	USD 22,391,563	-5,292	USD -335,279	USD 86.75	USD 86.28
2025-11-07 (Friday)	263,408	USD 22,726,842	USD 22,726,842	-4,536	USD -257,394	USD 86.28	USD 85.78
2025-11-06 (Thursday)	267,944	USD 22,984,236	USD 22,984,236	4,524	USD 754,222	USD 85.78	USD 84.39
2025-11-05 (Wednesday)	263,420	USD 22,230,014	USD 22,230,014	0	USD 139,613	USD 84.39	USD 83.86
2025-11-04 (Tuesday)	263,420	USD 22,090,401	USD 22,090,401	-369	USD 330,446	USD 83.86	USD 82.49
2025-11-03 (Monday)	263,789	USD 21,759,955	USD 21,759,955	0	USD -920,623	USD 82.49	USD 85.98
2025-10-31 (Friday)	263,789	USD 22,680,578	USD 22,680,578	0	USD -79,137	USD 85.98	USD 86.28
2025-10-30 (Thursday)	263,789	USD 22,759,715	USD 22,759,715	0	USD -79,137	USD 86.28	USD 86.58
2025-10-29 (Wednesday)	263,789	USD 22,838,852	USD 22,838,852	0	USD -118,705	USD 86.58	USD 87.03
2025-10-28 (Tuesday)	263,789	USD 22,957,557	USD 22,957,557	0	USD -255,875	USD 87.03	USD 88
2025-10-27 (Monday)	263,789	USD 23,213,432	USD 23,213,432	1,508	USD 266,467	USD 88	USD 87.49

Share Trades of MRK by Blackrock for IE00B6SPMN59

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-11	BUY	5,278	91.065	87.260	87.641	GBX 462,567	87.46
2025-11-10	SELL	-5,292	87.370	85.800	85.957	GBX -454,884	87.46 Profit of 7,956 on sale
2025-11-07	SELL	-4,536	86.570	85.240	85.373	GBX -387,252	87.47 Profit of 9,496 on sale
2025-11-06	BUY	4,524	86.170	84.350	84.532	GBX 382,423	87.48
2025-11-04	SELL	-369	84.960	82.035	82.328	GBX -30,379	87.51 Profit of 1,913 on sale
2025-10-27	BUY	1,508	88.295	87.030	87.157	GBX 131,432	87.56
2025-10-22	SELL	-754	88.790	87.030	87.206	GBX -65,753	87.56 Profit of 269 on sale
2025-10-20	BUY	2,262	87.000	85.030	85.227	GBX 192,783	87.57
2025-10-15	SELL	-1,508	84.690	83.610	83.718	GBX -126,247	87.63 Profit of 5,894 on sale
2025-10-14	BUY	754	85.680	84.150	84.303	GBX 63,564	87.64
2025-10-03	BUY	746	90.700	88.100	88.360	GBX 65,917	87.63
2025-09-30	BUY	376	84.000	78.400	78.960	GBX 29,689	87.63
2025-09-25	BUY	376	79.875	77.600	77.827	GBX 29,263	87.80
2025-09-24	SELL	-2,101	80.115	79.330	79.409	GBX -166,837	87.85 Profit of 17,740 on sale
2025-09-09	SELL	-822			84.610*		88.00 Profit of 72,333 on sale
2025-07-30	SELL	-2,807	83.580	81.520	81.726	GBX -229,405	88.12 Profit of 17,938 on sale
2025-07-29	BUY	10,556	82.890	76.660	77.283	GBX 815,799	88.15
2025-07-16	SELL	-5,655	82.640	81.460	81.578	GBX -461,324	88.23 Profit of 37,637 on sale
2025-07-14	SELL	-754	84.300	83.110	83.229	GBX -62,755	88.31 Profit of 3,830 on sale
2025-07-11	SELL	-1,131	84.130	82.260	82.447	GBX -93,248	88.34 Profit of 6,667 on sale
2025-07-10	SELL	-379	85.000	83.170	83.353	GBX -31,591	88.37 Profit of 1,902 on sale
2025-07-09	SELL	-754	84.480	81.890	82.149	GBX -61,940	88.40 Profit of 4,715 on sale
2025-07-07	BUY	375	81.540	80.150	80.289	GBX 30,108	88.50
2025-07-03	SELL	-5,655	82.600	80.700	80.890	GBX -457,433	88.61 Profit of 43,651 on sale
2025-07-02	SELL	-750	82.790	81.894	81.983	GBX -61,487	88.65 Profit of 5,002 on sale
2025-06-23	SELL	-756	80.220	78.990	79.113	GBX -59,809	88.91 Profit of 7,407 on sale
2025-06-20	SELL	-378	79.920	78.600	78.732	GBX -29,761	88.98 Profit of 3,875 on sale
2025-06-18	SELL	-730	80.310	77.100	77.421	GBX -56,517	89.13 Profit of 8,545 on sale
2025-06-16	SELL	-4,534	81.350	79.710	79.874	GBX -362,149	89.27 Profit of 42,599 on sale
2025-06-13	SELL	-19,204	82.440	81.450	81.549	GBX -1,566,067	89.33 Profit of 149,362 on sale
2025-06-12	SELL	-16,972	82.110	80.070	80.274	GBX -1,362,410	89.38 Profit of 154,614 on sale
2025-06-11	SELL	-756	81.680	79.980	80.150	GBX -60,593	89.45 Profit of 7,034 on sale
2025-06-06	BUY	1,134	79.490	78.210	78.338	GBX 88,835	89.68
2025-06-05	BUY	1,516	78.550	77.250	77.380	GBX 117,308	89.78
2025-05-28	SELL	-1,131	77.725	75.590	75.803	GBX -85,734	90.42 Profit of 16,534 on sale
2025-05-27	BUY	1,134	78.200	77.050	77.165	GBX 87,505	90.53
2025-05-23	SELL	-3,402			77.580*		90.75 Profit of 308,736 on sale
2025-05-22	BUY	756	78.360	76.680	76.848	GBX 58,097	90.86
2025-05-20	BUY	3,402	79.180	77.422	77.597	GBX 263,986	91.10
2025-05-16	SELL	-150	76.165	74.368	74.547	GBX -11,182	91.36 Profit of 2,521 on sale
2025-05-15	BUY	1,512			74.800*		91.50
2025-05-14	SELL	-10,179			73.470*		91.67 Profit of 933,094 on sale
2025-05-13	BUY	754			76.630*		91.81
2025-05-12	BUY	1,877			80.430*		91.91
2025-05-09	SELL	-1,508			75.970*		92.06 Profit of 138,828 on sale
2025-05-08	BUY	1,131			77.650*		92.20
2025-05-07	SELL	-1,885			79.120*		92.32 Profit of 174,026 on sale
2025-04-30	SELL	-376	85.830	83.790	83.994	GBX -31,582	92.80 Profit of 3,312 on sale
2025-04-28	SELL	-2,262	83.680	82.400	82.528	GBX -186,678	92.98 Profit of 23,649 on sale
2025-04-23	BUY	377	80.200	78.240	78.436	GBX 29,570	93.38
2025-04-15	BUY	4,914	79.960	77.720	77.944	GBX 383,017	94.42
2025-04-14	BUY	754	80.010	78.360	78.525	GBX 59,208	94.59
2025-04-09	SELL	-2,220	81.990	76.000	76.599	GBX -170,050	95.12 Profit of 41,125 on sale
2025-04-08	BUY	1,112	83.270	77.540	78.113	GBX 86,862	95.32
2025-04-04	BUY	2,227	86.260	81.090	81.607	GBX 181,739	95.66
2025-04-02	BUY	1,077			86.600*		95.77
2025-04-01	SELL	-3,336			87.120*		95.88 Profit of 319,847 on sale
2025-03-31	BUY	17,512			89.760*		95.95
2025-03-28	BUY	2,224			89.230*		96.04
2025-03-27	BUY	4,343			87.600*		96.15
2025-03-26	BUY	11,085			88.110*		96.26
2025-03-25	BUY	7,574			87.870*		96.37
2025-03-24	SELL	-1,112			92.310*		96.42 Profit of 107,223 on sale
2025-03-21	SELL	-108,507			93.110*		96.47 Profit of 10,467,522 on sale
2025-03-19	BUY	1,561			94.020*		96.53
2025-03-17	SELL	-3,224			94.790*		96.58 Profit of 311,371 on sale
2025-03-14	SELL	-1,612			94.570*		96.61 Profit of 155,733 on sale
2025-03-13	SELL	-1,612			94.710*		96.64 Profit of 155,779 on sale
2025-03-12	SELL	-3,224			93.350*		96.69 Profit of 311,718 on sale
2025-03-07	BUY	4,833			94.650*		96.77
2025-02-28	BUY	4,833	92.350	90.710	90.874	GBX 439,194	97.04
2025-02-26	BUY	6,444	91.370	88.860	89.111	GBX 574,231	97.29
2025-02-21	BUY	9,666	89.530	87.010	87.262	GBX 843,475	97.66
2025-02-18	BUY	3,222	83.590	81.040	81.295	GBX 261,932	98.37
2025-02-11	BUY	8,055	86.990	85.730	85.856	GBX 691,570	99.87
2025-02-07	BUY	3,222	88.600	87.120	87.268	GBX 281,178	100.47
2025-02-06	BUY	1,610	89.571	87.840	88.013	GBX 141,701	100.75
2025-02-05	BUY	4,830	90.740	87.995	88.270	GBX 426,342	101.02
2025-02-04	BUY	1,610	91.230	87.330	87.720	GBX 141,229	101.27
2025-01-31	SELL	-3,220	100.060	98.580	98.728	GBX -317,904	101.37 Profit of 8,507 on sale
2025-01-29	SELL	-3,220	99.150	97.390	97.566	GBX -314,163	101.52 Profit of 12,728 on sale
2024-12-10	SELL	-1,607	103.770	100.750	101.052	GBX -162,391	102.11 Profit of 1,706 on sale
2024-12-09	SELL	-1,607	105.070	102.330	102.604	GBX -164,885	102.06 Loss of -875 on sale
2024-11-27	SELL	-3,212	103.450	101.640	101.821	GBX -327,049	101.98 Profit of 504 on sale
2024-11-21	SELL	-6,424	100.480	96.950	97.303	GBX -625,074	102.30 Profit of 32,091 on sale
2024-11-20	SELL	-3,210	98.840	96.660	96.878	GBX -310,978	102.57 Profit of 18,266 on sale
2024-11-18	SELL	-3,210	97.290	95.420	95.607	GBX -306,898	103.32 Profit of 24,761 on sale
2024-11-12	SELL	-9,630	100.760	98.500	98.726	GBX -950,731	103.64 Profit of 47,290 on sale
2024-11-08	SELL	-25,680	103.230	101.020	101.241	GBX -2,599,869	103.69 Profit of 62,835 on sale
2024-11-07	SELL	-11,228	101.690	100.850	100.934	GBX -1,133,287	103.88 Profit of 33,095 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer